A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients

► Perospirone and aripiprazole showed good efficacy for the treatment of schizophrenia. ► No significant difference was found in efficacy and tolerability between two drugs. ► Perospirone may improve anxiety and depression earlier than aripiprazole.